Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

December 2, 2022

Study Completion Date

December 2, 2022

Conditions
Cognitive Decline
Interventions
DRUG

Souvenaid

Souvenaid is an oral beverage that contains a vitamin mixture (Vitamin A, B1, B2, B3, B5, D) plus three main active ingredients: omega-3 fatty acids, uridine monophosphate, and choline.

OTHER

Placebo

The Placebo used in this study is an oral beverage vitamin mixture containing Vitamins A, B1, B2, B3 and B5.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

American Academy of Neurology

OTHER

lead

University of Miami

OTHER